(ANIP) ANI Pharmaceuticals - Performance 6% in 12m
ANIP performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
65.87%
#11 in Peer-Group
Rel. Strength
46.19%
#4131 in Stock-Universe
Total Return 12m
5.96%
#74 in Peer-Group
Total Return 5y
136.92%
#11 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 9.90 |
| High / Low | USD |
|---|---|
| 52 Week High | 72.95 USD |
| 52 Week Low | 53.35 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 79.91 |
| Buy/Sell Signal +-5 | 0.28 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ANIP (6%) vs XLV (-5.3%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-0.36% | 135% | 355% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.34% | 16.6% | 86.1% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-2.05% | -15.3% | 417% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.68% | 4.53% | 55.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-4.16% | 7.17% | 55.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-2.74% | -5.77% | 51.3% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-8.26% | -8.51% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
4.73% | 19.8% | 64.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: ANIP vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ANIP
| Total Return (including Dividends) | ANIP | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 5.14% | 0.95% | 4.08% |
| 3 Months | 1.50% | 1.54% | 19.65% |
| 12 Months | 5.96% | -5.25% | 12.88% |
| 5 Years | 136.92% | 45.67% | 113.48% |
| Trend Score (consistency of price movement) | ANIP | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 53.8% | 24.8% | 86.9% |
| 3 Months | -38.8% | -21.1% | 97.2% |
| 12 Months | 34.5% | -78.2% | 46% |
| 5 Years | 87.4% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th63.50 | 4.15% | 1.02% |
| 3 Month | %th21.00 | -0.04% | -15.17% |
| 12 Month | %th62.50 | 11.83% | -6.13% |
| 5 Years | %th94.50 | 62.64% | 10.98% |
FAQs
Does ANI Pharmaceuticals (ANIP) outperform the market?
Yes,
over the last 12 months ANIP made 5.96%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.25%.
Over the last 3 months ANIP made 1.50%, while XLV made 1.54%.
Performance Comparison ANIP vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ANIP vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.2% | 1.1% | 11.6% | -7% |
| US NASDAQ 100 | QQQ | 1.4% | 1.1% | 10.3% | -5% |
| German DAX 40 | DAX | -0.9% | 3.3% | -0.4% | -26% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.3% | -0.1% | 7.3% | -15% |
| Hongkong Hang Seng | HSI | 2.4% | 2.7% | -8.6% | -31% |
| India NIFTY 50 | INDA | 2.2% | 5.1% | 12.2% | 8% |
| Brasil Bovespa | EWZ | 6.7% | 3.3% | -4.4% | 3% |
ANIP vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.5% | 3% | 8.1% | -17% |
| Consumer Discretionary | XLY | 1.2% | 2.6% | 19.4% | -11% |
| Consumer Staples | XLP | 2.6% | 5.3% | 12.6% | -1% |
| Energy | XLE | -0.7% | -0% | 18.1% | 3% |
| Financial | XLF | 2.2% | 1.6% | 7.9% | -22% |
| Health Care | XLV | 0.7% | 4.2% | 21.6% | 11% |
| Industrial | XLI | 0.4% | 0.3% | 4.6% | -19% |
| Materials | XLB | 0.3% | 0.8% | 8.2% | -0% |
| Real Estate | XLRE | 1.7% | 5.7% | 12.2% | -5% |
| Technology | XLK | 1.3% | -1.7% | 7.4% | -3% |
| Utilities | XLU | 0.4% | 2.3% | 9.3% | -16% |
| Aerospace & Defense | XAR | 0.9% | -1.4% | -6.5% | -43% |
| Biotech | XBI | -2.4% | 1.5% | 21.3% | 13% |
| Homebuilder | XHB | -2.1% | -3.2% | 16% | -0% |
| Retail | XRT | 0.9% | 2.4% | 17.2% | -5% |
ANIP vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1% | -0.15% | 26.6% | 12% |
| Natural Gas | UNG | 4.5% | 13.3% | 40% | 11% |
| Gold | GLD | 1.6% | 5.3% | -3.3% | -34% |
| Silver | SLV | 0.5% | 3.6% | -2.2% | -14% |
| Copper | CPER | -7.8% | -8.2% | -9.3% | -17% |
ANIP vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.2% | 3.5% | 16.1% | 8% |
| iShares High Yield Corp. Bond | HYG | 1.6% | 3.9% | 15.1% | -4% |